John Brimacombe is a successful entrepreneur, investor and scale-up executive. Brimacombe previously served as Executive Chairman of Linguamatics prior to its acquisition by IQVIA (NYSE:IQV) and then joined IQVIA full-time to integrate and scale the business. Brimacombe was also previously an Operating Partner at Sussex Place Ventures, the venture capital fund associated with the London Business School. Brimacombe has extensive experience as a non-executive director, Chairman and adviser from start-up to public markets with significant understanding of the exit process. He served as lead investor and long-term board member at the breast cancer surgical guidance leader, Endomag (www.endomag.com) which was acquired by Hologic for $310M. Brimacombe graduated in Law and Computer Science from Trinity College, Cambridge.
